{"id":4560,"date":"2018-07-14T07:10:56","date_gmt":"2018-07-14T11:10:56","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4560"},"modified":"2018-07-14T07:10:56","modified_gmt":"2018-07-14T11:10:56","slug":"ipo-pipeline-update-7-14-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-7-14-18\/","title":{"rendered":"IPO Pipeline Update: 7.14.18"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of July 14, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4561\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM.png\" alt=\"Screen Shot 2018-07-14 at 7.08.27 AM\" width=\"1068\" height=\"376\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM.png 1068w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM-600x211.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM-300x106.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/07\/Screen-Shot-2018-07-14-at-7.08.27-AM-1024x361.png 1024w\" sizes=\"(max-width: 1068px) 100vw, 1068px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 22, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline in this article.<\/p>\n<p>NEW FILINGS<\/p>\n<p>Company: Sonos, Inc.<br \/>\nSymbol: OPRA<br \/>\nDescription: Sonos was founded with a clear mission\u2014to fill every home with music. This mission led them to invent wireless multi-room home audio.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Allen &amp; Co., RBC, Jefferies, KKR<br \/>\nCo-Manager(s): Raymond James, Stifel<br \/>\nFiled: 7-6-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Arlo Technologies, Inc.<br \/>\nSymbol: ARLO<br \/>\nDescription: Arlo combines an intelligent cloud infrastructure and mobile app with a variety of smart connected devices that transform the way people experience the connected lifestyle.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, Deutsche Bank Securities, Guggenheim Securities<br \/>\nCo-Manager(s): Raymond James, Cowen, Imperial Capital<br \/>\nFiled: 7-6-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Vaccinex, Inc.<br \/>\nSymbol: VCNX<br \/>\nDescription: They are a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Oppenheimer &amp; Co., BTIG<br \/>\nCo-Manager(s): Ladenburg Thalmann<br \/>\nFiled: 7-9-18<br \/>\nListed Cash Raise: $46m<\/p>\n<p>Company: CURE Pharmaceuticals<br \/>\nSymbol: CURR<br \/>\nDescription: They are a drug formulation and delivery technology company that researches and manufactures novel dosage forms to improve drug safety, efficacy and patient adherence.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): TBD<br \/>\nFiled: 7-9-18<br \/>\nListed Cash Raise: TBD<\/p>\n<p>Company: Select Interior Concepts, Inc.<br \/>\nSymbol: SIC<br \/>\nDescription: They are a premier installer and nationwide distributor of interior building products with leading market positions in residential interior design services in highly attractive markets.tures novel dosage forms to improve drug safety, efficacy and patient adherence.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): TBD<br \/>\nFiled: 7-9-18<br \/>\nListed Cash Raise: TBD<\/p>\n<p>Company: ToughBuilt Industries, Inc.<br \/>\nSymbol: TBLT<br \/>\nDescription: They market and distribute various home improvement and construction product lines for both the do-it-yourself and professional markets under TOUGHBUILT brand name, within the global multi-billion dollar per year tool market industry.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Joseph Gunnar<br \/>\nFiled: 7-9-18<br \/>\nListed Cash Raise: $17.25m<\/p>\n<p>Company: YayYo, Inc.<br \/>\nSymbol: YAYO<br \/>\nDescription: The Company is a holding company operating through its wholly-owned subsidiaries, including Distinct Cars, LLC, a Delaware limited liability company , Savvy LLC, a Delaware limited liability company , Rideyayyo LLC, a Delaware limited liability company and Rideshare Car Rentals LLC, a Delaware limited liability company.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): TBD<br \/>\nFiled: 7-10-18<\/p>\n<p>Company: CNFinance Holdings Limited<br \/>\nSymbol: TBD<br \/>\nDescription: They are a leading home equity loan service provider in China with established business infrastructure.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Credit Suisse<br \/>\nFiled: 7-11-18<br \/>\nListed Cash Raise: $200m<\/p>\n<p>Company: CBM Bancorp, Inc<br \/>\nSymbol: CBMB<br \/>\nDescription: Chesapeake Bank of Maryland is a federally chartered savings bank headquartered in Baltimore, Maryland.<br \/>\nTrade Date: TBD<br \/>\nShares: 3.68 million<br \/>\nPrice Range: $10.00-$10.00<br \/>\nUnderwriter(s): Raymond James<br \/>\nFiled 7-13-18<br \/>\nNote: This is a Subscription Offering<\/p>\n<p>Company: Urovant Sciences Ltd.<br \/>\nSymbol: UROV<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Jefferies, Cowen<br \/>\nFiled: 7-13-18<br \/>\nListed Cash Raise: $150m<\/p>\n<p>Company: Mesa Air Group, Inc.<br \/>\nSymbol: MESA<br \/>\nDescription: They are a regional air carrier providing scheduled passenger service to 110 cities in 38 states, the District of Columbia, Canada, Mexico and the Bahamas.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Raymond James, BofA Merrill Lynch<br \/>\nCo-Manager(s): Cowen, Stifel, Imperial Capital<br \/>\nFiled: 7-13-18<br \/>\nListed Cash Raise: $150m<\/p>\n<p>TERMS ADDED<\/p>\n<p>Company: Rubius Therapeutics, Inc.<br \/>\nSymbol: RUBY<br \/>\nDescription: They are pioneering the development of a new class of medicines, Red Cell Therapeutics, or RCTs.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 9.53 million<br \/>\nPrice Range: $20.00-$22.00<br \/>\nUnderwriter(s):J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Bloom Energy Corporation<br \/>\nSymbol: BE<br \/>\nDescription: Their mission is to make clean, reliable, and affordable energy for everyone in the world.<br \/>\nTrade Date: 7\/25<br \/>\nShares: 18.0 million<br \/>\nPrice Range: $13.00-$15.00<br \/>\nUnderwriter(s): J.P. Morgan, Morgan Stanley, Credit Suisse, KeyBanc Capital, BofA Merrill Lynch<br \/>\nCo-Manager(s): Baird, Cowen, HSBC, Oppenheimer &amp; Co., Raymond James<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Crinetics Pharmaceuticals, Inc.<br \/>\nSymbol: CRNX<br \/>\nDescription: They are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.<br \/>\nTrade Date: 7\/18<br \/>\nShares: 5.0 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, Piper Jaffray<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Allakos Inc.<br \/>\nSymbol: ALLK<br \/>\nDescription: They are are a clinical stage biotechnology company developing AK002, our wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 6 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s):Goldman Sachs, Jefferies<br \/>\nCo-Manager(s): William Blair<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Constellation Pharmaceuticals, Inc.<br \/>\nSymbol: CNST<br \/>\nDescription: They are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 5.34 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): J.P. Morgan, Jefferies, BMO Capital Markets<br \/>\nCo-Manager(s): Oppenheimer &amp; Co.<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: First Western Financial, Inc.<br \/>\nSymbol: MYFW<br \/>\nDescription: First Western Financial, Inc. is a financial holding company headquartered in Denver, Colorado.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 1.85 million<br \/>\nPrice Range: $19.00-$21.00<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, Stephens, Sandler O&#8217; Neill<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: AFG Holdings, Inc.<br \/>\nSymbol: AFGL<br \/>\nDescription: They are a leading original equipment manufacturer that designs and manufactures highly-engineered, mission critical equipment and provides complementary consumable products, parts and aftermarket services<br \/>\nTrade Date: 7\/19<br \/>\nShares: 18.2 million<br \/>\nPrice Range: $15.00-$18.00<br \/>\nUnderwriter(s): Goldman Sachs, Credit Suisse, Simmons &amp; Company International, Barclays, Citigroup, Evercore ISI, Wells Fargo Securities<br \/>\nCo-Manager(s): Jefferies, Raymond James, Tudor, Pickering, Holt &amp; Co.<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Establishment Labs Holdings Inc.<br \/>\nSymbol: ESTA<br \/>\nDescription: They are a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 3.125 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): Jefferies, Cowen, BTIG<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Tilray, Inc.<br \/>\nSymbol: TLRY<br \/>\nDescription: They are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized.<br \/>\nTrade Date: 7\/19<br \/>\nShares: 9.0 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): Cowen, Roth Capital, Northland Capital<br \/>\nTerms Added: 7-9-18<\/p>\n<p>Company: Replimune Group, Inc.<br \/>\nSymbol: REPL<br \/>\nDescription: They are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients.<br \/>\nTrade Date: 7\/20<br \/>\nShares: 6.7 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets<br \/>\nTerms Added: 7-10-18<\/p>\n<p>Company: Coastal Financial Corporation<br \/>\nSymbol: CCB<br \/>\nDescription: They are a bank holding company that operates through our wholly owned subsidiary, Coastal Community Bank.<br \/>\nTrade Date: Week of 7\/16<br \/>\nShares: 2.72 million<br \/>\nPrice Range: $13.00-$15.00<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, Hovde Group<br \/>\nTerms Added: 7-10-18<\/p>\n<p>Company: Liquidia Technologies, Inc.<br \/>\nSymbol: LQDA<br \/>\nDescription: They are a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients.<br \/>\nTrade Date: 7\/26<br \/>\nShares: 4.54 million<br \/>\nPrice Range: $10.00-$12.00<br \/>\nUnderwriter(s): Jefferies, Cowen<br \/>\nCo-Manager(s): Needham &amp; Co., Wedbush PacGrow<br \/>\nTerms Added: 7-13-18<\/p>\n<p>Company: Aurora Mobile Limited<br \/>\nSymbol: JG<br \/>\nDescription: They are a leading mobile big data solutions platform in China.<br \/>\nTrade Date: TBD<br \/>\nShares: 12 million<br \/>\nPrice Range: $8.50-$10.50<br \/>\nUnderwriter(s): Goldman Sachs, Credit Suisse<br \/>\nTerms Added: 7-13-18<\/p>\n<p>Company: Opera Limited<br \/>\nSymbol: OPRA<br \/>\nDescription: They are one of the world&#8217;s leading browser providers and an influential player in the field of integrated AI-driven digital content discovery and recommendation platforms.<br \/>\nTrade Date: TBD<br \/>\nShares: 9 million<br \/>\nPrice Range: $10.00-$12.00<br \/>\nUnderwriter(s): CICC, Citigroup<br \/>\nTerms Added: 7-13-18<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of July 14, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS IPO Boutique[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4560","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4560"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4560\/revisions"}],"predecessor-version":[{"id":4562,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4560\/revisions\/4562"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}